View |
|
DRP-12985-01
|
Losartan Potassium + Amlodipine (as besilate)
|
None
|
50 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist/Calcium Channel Blocker
|
Ajanta Pharma Limited
|
India
|
Renewal
|
11 September 2023
|
24 October 2028
|
View |
|
DRP-12991-04
|
Mupirocin
|
Mupin
|
20 mg / g (2% w/w)
|
Topical Ointment
|
Antibacterial
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
03 October 2023
|
14 November 2027
|
View |
|
DRP-130-05
|
Cefalexin (As Monohydrate)
|
Flaximed
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
Cephalosporin (First Generation)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
10 October 2023
|
30 May 2027
|
View |
|
DRP-13059-02
|
Telmisartan + Amlodipine (as besilate)
|
Telmefixx Plus
|
40 mg/5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 October 2023
|
24 November 2027
|
View |
|
DRP-13116-01
|
Sitagliptin (as phosphate)
|
Sitastar-100
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 September 2023
|
02 December 2027
|
View |
|
DRP-13117-01
|
Sitagliptin (as phosphate)
|
Sitastar-50
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
02 December 2027
|
View |
DRP-13236-06_PI_01.pdf
|
DRP-13236-06
|
Omeprazole (as sodium)
|
Omexac-40
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
04 October 2023
|
06 January 2028
|
View |
|
DRP-13237-04
|
Ursodeoxycholic Acid
|
None
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
06 January 2028
|
View |
|
DRP-13237-05
|
Ursodeoxycholic Acid
|
Ursoden
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 October 2023
|
06 January 2028
|
View |
|
DRP-13238-05
|
Ursodeoxycholic Acid
|
Ursoden
|
250 mg
|
Capsule
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 October 2023
|
06 January 2028
|
View |
|
DRP-13249-04
|
Hydrocortisone (as sodium succinate)
|
Hydrocent
|
100 mg
|
Powder for Injection (I.M ./I.V.)
|
Corticosteroid (Glucocorticoid)
|
United Biotech Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 October 2023
|
10 January 2028
|
View |
|
DRP-13278-01
|
Sitagliptin (as phosphate) + Metformin Hydrochloride
|
Sitajack-M
|
50 mg / 500 mg
|
Film-coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Novagen Healthcare Private Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
19 January 2025
|
View |
|
DRP-13304-02
|
Etoricoxib
|
Coxido 120
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory and Anti-rhematic Product (Coxib)
|
Hetero Labs Limited
|
India
|
CLIDP Conversion
|
10 October 2023
|
20 January 2028
|
View |
|
DRP-13327-01
|
Amlodipine (as besilate)
|
None
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 October 2023
|
27 January 2028
|
View |
|
DRP-13405-02
|
Etoricoxib
|
Coxido 90
|
90 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory and Anti-rheumatic Product (Coxib)
|
Hetero Labs Limited (Unit III)
|
India
|
CLIDP Conversion
|
11 September 2023
|
14 February 2028
|
View |
|
DRP-13423-01
|
Doxorubicin Hydrochloride
|
None
|
50 mg
|
Lyophilized Powder for Injection (I.V.)
|
Antineoplastic (Anthracycline)
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
28 September 2023
|
15 February 2028
|
View |
|
DRP-13519-01
|
Tamsulosin Hydrochloride
|
Tamsukem
|
400 mcg
|
Prolonged-Release Tablet
|
Alpha-Adrenoreceptor Antagonist
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
11 September 2023
|
03 March 2028
|
View |
|
DRP-13567-01
|
Cefixime (as trihydrate)
|
None
|
100 mg / 5 mL
|
Granules for Suspension
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
02 October 2023
|
14 August 2026
|
View |
|
DRP-13608-02
|
Levocetirizine Dihydrochloride
|
Alerix
|
2.5 mg / 5 mL
|
Syrup
|
Antihistamine
|
Enicar Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 September 2023
|
17 March 2028
|
View |
|
DRP-13665-01
|
Cefixime (as Trihydrate)
|
Gicefix
|
200 mg
|
Dispersible Tablet (Trusil Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
Innova Captab Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 September 2023
|
28 March 2028
|